SNJ101
The first plasmin-independent thrombolytic agent
to revolutionize the treatment of thrombotic disorders
SNJ101
The first plasmin-independent thrombolytic agent
to revolutionize the treatment of thrombotic disorders
The first plasmin-independent thrombolytic agent
to revolutionize the treatment of thrombotic disorders
The first plasmin-independent thrombolytic agent
to revolutionize the treatment of thrombotic disorders
Copyright © 2023 SNJ Pharma Inc. - All Rights Reserved.